Cryoablation of Breast Cancer Tumors Boosts Immune Response in Distant Tumors
Author Information
Author(s): Sardela de Miranda Flávia, Martinez-Marin Dalia, Babcock Rachel L., Castro Maribel, Boligala Geetha P., Khan Sonia Y., Furr Kathryn L., Castro-Piedras Isabel, Wagner Nicholas, Robison Dakota E., Daniele Karla, Singh Sharda P., Pruitt Kevin, Melkus Michael W., Layeequr Rahman Rakhshanda
Primary Institution: Texas Tech University Health Sciences Center
Hypothesis
Cryoablation of primary breast cancer tumors enhances the systemic immune response, leading to an abscopal effect in distant tumors.
Conclusion
Cryoablation improves tumor elimination by increasing anti-tumor immune cell frequencies in distant tumors.
Supporting Evidence
- Cryoablation leads to smaller abscopal tumors with increased anti-tumor immune cells.
- Enhanced frequencies of NK cells and migratory dendritic cells were observed post-cryoablation.
- Gene expression analysis showed significant changes in immune-related pathways after cryoablation.
Takeaway
When doctors freeze a breast tumor, it helps the body fight cancer not just in that tumor but also in other tumors far away.
Methodology
Mice with breast cancer were treated with either cryoablation or surgical resection, and immune responses were analyzed through flow cytometry and RNA sequencing.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
Naïve female BALB/c mice, aged 8-11 weeks.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website